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magnitude of response is dependent on time points of 
evaluation. The predictive power of these changes on long 
term treatment outcome is object of ongoing prospective 
study. 
    
EP-1269   
From datasets to predictive models in cervical cancer: an 
ontology to mine data for large data-base 
R. Autorino1, M.A. Gambacorta1, L. Tagliaferri1, M. 
Campitelli1, E. Meldolesi1, R. Gatta1, V. Frascino1, N. 
Dinapoli1, A. Nardangeli1, G.C. Mattiucci1, A. Damiani1, V. 
Valentini1 
1Università Cattolica del Sacro Cuore, Radiation Oncology 
Department Gemelli ART, Rome, Italy  
 
Purpose/Objective: The scenario in cancer research is 
currently progressively moving on the analysis of established 
large database, realized by crossing and combining multiple 
data. These data must be analyzed by ad-hoc computer 
softwares to produce models that can predict the treatment 
outcomes in a reliable way. In order to make possible the 
integration and analysis of data from different cancer centers 
and cancer registries, to elaborate predictive models from 
large datasets there is the need of an 'ontology', a kind of 
dictionary that standardizes the medical terminologies. 
Materials and Methods: We defined the ontology evaluated 
by a multi-professional technical commission composed by a 
mathematician, an engineer, a doctor with experience in 
data storage, a programmer and a software expert. 
Results: More than 200 clinical, instrumental and imaging 
variables were cataloged and stored in three different levels. 
The first level (Registry Level) includes patient-related 
variables (age, sex, ethnicity, height, weight, etc.) that can 
be easily used for epidemiological analyzes. The second level 
(Procedure Level) includes data on the clinical presentation 
and pathology of the tumor, therapeutic procedures and their 
side effects. The third and final level (Research Level) will 
provide for the storage of data in advanced searches. In our 
ontology we preferably used concepts from existing and 
mature terminological systems (e.g. NCI Thesaurus, CTCAE, 
SNOMED-CT). We used field types as text, number, date, 
table, files. The chosen standard file formats were 'DICOM' 
for image and 'TXT files' for data treatment. The toxicity was 
stored with CTC4 scale and the RTOG scale (for back 
comparison with retrospective studies). 
Conclusions: A formal ontology is necessary to obtain a 
standardized and organized dataset. This allows to create a 
system to share and to analyze data from large multi-centers 
database. These data can be used to elaborate predictive 
models to tailored treatment in daily clinical practice.  
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Purpose/Objective: Descriptive analysis of high-risk 
neuroblastoma´s treated with volumetric modulated arc 
therapy (VMAT) based in 'SIOP-Europe 2011 high-risk 
neuroblastoma' guidelines. 
Materials and Methods: Based in International 
Neuroblastoma Staging System (INSS), we classify high-risk 
neuroblastoma those in stage 2, 3, 4 y 4S plus N-myc 
amplification, or stage 4 over one year-old. From september 
2010-2014 seventeen patients were treated with VMAT. 76.4% 
were boys and 23.6% girls, with a medium age of 37 months. 
N-myc amplification was positive in 47%. With INSS criteria, 
we noted:  
 
Stage (based in INSS) 
4 76.4%
3 11.8%
2 5.9% 
4S 5.9% 
Anatomical location 
Adrenal gland 64.7%
Abdominal 17.6%
Bilateral adrenal gland 5.8% 
Cervical 5.8% 
Thoraco-abdominal 5.8% 
 
After induction chemotherapy (COJEC), tumor exeresis and 
autologous blood marrow transplantation, all patients 
considered eligible for participation in this study were 
treated with VMAT (21 Gy maximum dose, fractioned over in 
14 sessions, 1,5 Gy each one) over the primary tumor area.  
Results: After medium folllow-up of 23 months (8-41), 41% 
are alive without tumor, 11.7% are alive with tumor, 23,5% 
have died because the tumor, 17.6% have died because an 
intercurrent cause, and 5.8% are dead by an unclearly 
cause.The radiotherapy tolerance was acceptable: 23.5% 
presented acute gastrointestinal toxicity grade 1-2 related to 
treatment. No chronicle toxicity has been noted.  
Conclusions: The N-myc amplification is clearly associated 
with major relapse risk and dead related with progression. 
This analysis revealed that VMAT in high-risk neuroblastoma´s 
treatment contributes to locoregional control with aceptable 
tolerance. There are no enough studies that compare VMAT 
with other techniques in high-risk neuroblastoma´s 
treatment. It is important the long follow-up of these 
patients to evaluate second neoplasms incidence, 
locorregional control and increase survival. 
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